Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 80651-80700 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04833426
Impact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomy
PHASE3Recruiting
140 participants
Started: Dec 12, 2022 · Completed: Dec 31, 2029
3 conditions2 sponsors10 locations
NCT05641974
Effect of Helpers Program On-line Training on Smoking Relapse and Social Networks
NAActive, not recruiting
940 participants
Started: Dec 12, 2022 · Completed: Feb 27, 2027
2 conditions2 sponsors1 location
NCT05682235
Therapeutic Exercise and Education in Pain Neurophysiology to Improve Pain Intensity in Women With Endometriosis. Clinical Trial.
NAActive, not recruiting
40 participants
Started: Dec 12, 2022 · Completed: Mar 12, 2025
1 condition1 sponsor1 location
NCT05633654
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
PHASE3Recruiting
1,514 participants
Started: Dec 12, 2022 · Completed: Aug 31, 2031
1 condition4 sponsors225 locations
NCT05662345
ACT-MBC: A Study of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer (MBC)
N/AActive, not recruiting
65 participants
Started: Dec 12, 2022 · Completed: Oct 30, 2026
1 condition2 sponsors4 locations
NCT05340582
Co-administration of Acetaminophen With Ibuprofen to Improve Duct-Related Outcomes in Extremely Premature Infants
PHASE2Recruiting
310 participants
Started: Dec 12, 2022 · Completed: Apr 30, 2027
1 condition9 sponsors9 locations
NCT05364502
(HALT) Embrace Hydrogel Embolic System (HES) Study of Embolization in Peripheral Arterial Bleeds
NARecruiting
130 participants
Started: Dec 12, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor22 locations
NCT06100354
Study of Patient Preferences in Relation to the Fitting of a Personalized and Connected Joint Prosthesis.
N/AActive, not recruiting
200 participants
Started: Dec 12, 2022 · Completed: Jun 12, 2025
2 conditions1 sponsor1 location
NCT05609708
Technological Development and Clinical Parallel Testing of PGT-G
N/ARecruiting
55 participants
Started: Dec 12, 2022 · Completed: Nov 1, 2025
1 condition1 sponsor1 location
NCT05682742
Clinical Investigation of the da Vinci Surgical System
NAActive, not recruiting
53 participants
Started: Dec 12, 2022 · Completed: Aug 31, 2028
10 conditions1 sponsor4 locations
NCT05747443
Multilevel Interventions to Increase Adherence to Lung Cancer Screening
NAActive, not recruiting
1,837 participants
Started: Dec 12, 2022 · Completed: Jun 30, 2026
2 conditions3 sponsors1 location
NCT05829226
A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS)
PHASE1Recruiting
90 participants
Started: Dec 12, 2022 · Completed: Mar 31, 2026
2 conditions1 sponsor9 locations
NCT05756959
Myopia Control Combined PBM With Myopic Defocus Lens in Children
NARecruiting
304 participants
Started: Dec 12, 2022 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT05480462
Immunogenicity and Safety of Vaccine Against Tetanus and Diphtheria.
PHASE3Active, not recruiting
200 participants
Started: Dec 12, 2022 · Completed: Jun 30, 2024
2 conditions1 sponsor2 locations
NCT05611190
CT-FFR-guided Strategy for In-stent Restenosis
NANot yet recruiting
294 participants
Started: Dec 12, 2022 · Completed: Dec 11, 2025
2 conditions1 sponsor0 locations
NCT05644704
Intelligent Sports Injury Prevention and Training System
NARecruiting
40 participants
Started: Dec 12, 2022 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT06956703
NAZA - Nottingham/Astra ZenecA Prospective IBD Cohort Study
N/ARecruiting
240 participants
Started: Dec 12, 2022 · Completed: Feb 28, 2027
4 conditions2 sponsors1 location
NCT05709392
Preterm DElayed Cord Clamping and Early Skin-to-Skin Contact: PreDECESS
NARecruiting
126 participants
Started: Dec 12, 2022 · Completed: Dec 11, 2028
5 conditions1 sponsor1 location
NCT05481476
Surufatinib Combined With Sintilimab and AG in First-line Therapy of Patients With Locally Advanced or Metastatic Pancreatic Cancer
PHASE2Active, not recruiting
32 participants
Started: Dec 12, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05298722
Prediction of Surgical Resectability After FOLFIRINOX Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: the Role of Diffusion Weighted Magnetic Resonance Imaging, Radiomics and Liquid Biopsy (PeRFormanCe Trial)
NARecruiting
45 participants
Started: Dec 12, 2022 · Completed: Mar 31, 2028
1 condition1 sponsor8 locations
NCT05710159
The iBlad App - a National, Exploratory Study on a Multimodality Smartphone App for Bladder Cancer Patients
N/ARecruiting
100 participants
Started: Dec 12, 2022 · Completed: Dec 30, 2024
1 condition3 sponsors2 locations
NCT05597098
Investigation of the Distinct Mechanisms Involved in Inflammatory Resolution Between Healthy Men and Women
EARLY_PHASE1Recruiting
34 participants
Started: Dec 12, 2022 · Completed: Oct 16, 2025
1 condition1 sponsor1 location
NCT06212141
Comparison of Bulk-Fill Composite Resins in Class II Restorations
NAActive, not recruiting
54 participants
Started: Dec 12, 2022 · Completed: Jun 15, 2024
1 condition1 sponsor1 location
NCT05677763
OM-85 in Paediatric Recurrent Respiratory Tract Infections With Wheezing Lower Respiratory Illness
PHASE4Active, not recruiting
525 participants
Started: Dec 12, 2022 · Completed: Sep 28, 2026
2 conditions1 sponsor42 locations
NCT05405803
To Improve Depressive Symptoms Using a Web-App
NARecruiting
300 participants
Started: Dec 12, 2022 · Completed: Oct 31, 2026
1 condition2 sponsors1 location
NCT05554939
Allogenic CD19-targeting CAR-γδT Cell Therapy in R/R NHL
PHASE1/PHASE2Recruiting
30 participants
Started: Dec 11, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor2 locations
NCT05502991
Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNA-level-relapse and Clinical-relapse Glioblastoma
PHASE2Not yet recruiting
60 participants
Started: Dec 11, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06229093
Multimodal Musical Stimulation for Healthy Neurocognitive Aging
NARecruiting
100 participants
Started: Dec 11, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05999695
Self-management of Patients With Acute Coronary Syndromes
NAEnrolling by invitation
104 participants
Started: Dec 11, 2022 · Completed: Aug 26, 2024
1 condition1 sponsor1 location
NCT05698498
Silicon Valley Guaranteed Income Project
NARecruiting
300 participants
Started: Dec 10, 2022 · Completed: Dec 31, 2026
1 condition5 sponsors2 locations
NCT05102721
Trial of Immunotherapy With Avelumab and Pepinemab As Second Line For Patients With Metastatic Pancreatic Adenocarcinoma
PHASE1/PHASE2Active, not recruiting
48 participants
Started: Dec 10, 2022 · Completed: Dec 31, 2028
1 condition2 sponsors1 location
NCT06180772
FIT FIRST FOR ALL - The Dose-Response Study
NAEnrolling by invitation
2,400 participants
Started: Dec 10, 2022 · Completed: Dec 24, 2024
1 condition3 sponsors1 location
NCT05849532
Home-based FES Training in People With Chronic Stroke
NARecruiting
30 participants
Started: Dec 10, 2022 · Completed: Mar 30, 2026
1 condition1 sponsor1 location
NCT05272735
HBV Vaccination of Healthy Volunteers to Evaluate the Composition of Germinal Centers
PHASE4Recruiting
12 participants
Started: Dec 10, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05467852
Didroxyprogesterone Promotes Natural Pregnancy in Infertile Patients With Endometriosis
PHASE3Not yet recruiting
300 participants
Started: Dec 10, 2022 · Completed: Dec 10, 2025
1 condition4 sponsors0 locations
NCT05626569
Anti-PD-1 Immunotherapy Combined With SBRT for Patients With Oligometastatic ESCC
PHASE2Recruiting
40 participants
Started: Dec 10, 2022 · Completed: Jan 1, 2026
2 conditions1 sponsor1 location
NCT05612256
Electrical Impedance Tomography for Identification of Optimal Positive End-expiratory Pressure in Newborn Infants
N/ARecruiting
86 participants
Started: Dec 10, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05651100
Safety and Efficacy of Sequential CD19 and CD22 Targeted CAR-T Therapy for Relapsed/Refractory B Cell Lymphoma
PHASE1/PHASE2Not yet recruiting
50 participants
Started: Dec 10, 2022 · Completed: Dec 10, 2025
1 condition2 sponsors1 location
NCT05562882
A Clinical Trial to Assess Safety and Efficacy of Daratumumab in the Treatment of Primary Immune Thrombocytopenia
PHASE2Active, not recruiting
60 participants
Started: Dec 10, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05621434
A Study to Evaluate Inetetamab + Pyrotinib + Chemotherapy in Previously Untreated HER2-Positive Metastatic Breast Cancer
PHASE2Not yet recruiting
63 participants
Started: Dec 10, 2022 · Completed: Dec 10, 2025
1 condition1 sponsor0 locations
NCT04196556
Effectiveness of an Intervention Programme for Childhood Obesity: FAMILIACT
NAActive, not recruiting
253 participants
Started: Dec 10, 2022 · Completed: Dec 14, 2024
1 condition1 sponsor1 location
NCT05602636
Analgesic Effect of Supraclavicular Block and Interscalene Analgesia Versus an Intercostobrachial Nerve Block Versus PCA in Forearm Surgery
PHASE4Recruiting
60 participants
Started: Dec 10, 2022 · Completed: Nov 30, 2024
4 conditions1 sponsor1 location
NCT05657483
Inflammatory Index as a Predictor for Endometrial Cancer: an Observational Study
N/ARecruiting
128 participants
Started: Dec 10, 2022 · Completed: Dec 10, 2024
2 conditions1 sponsor1 location
NCT05409794
Basal Plasma Lithium Levels and Suicidal Events
N/ARecruiting
158 participants
Started: Dec 9, 2022 · Completed: Jan 9, 2027
3 conditions1 sponsor1 location
NCT05486832
Safety and Performance of the Cardiovalve TR Replacement System
NARecruiting
100 participants
Started: Dec 9, 2022 · Completed: Dec 15, 2026
1 condition1 sponsor7 locations
NCT05524961
Bright Light Therapy for Non-motor Symptoms in Parkinson's Disease
NARecruiting
69 participants
Started: Dec 9, 2022 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05618392
Pain Assessment Following Placement of a Percutaneous Radiologic Gastrostomy and Predictive Factors
N/ARecruiting
50 participants
Started: Dec 9, 2022 · Completed: Jan 1, 2026
2 conditions1 sponsor1 location
NCT05302531
Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome
PHASE1Recruiting
10 participants
Started: Dec 9, 2022 · Completed: Feb 28, 2025
2 conditions4 sponsors1 location
NCT05513001
An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib
PHASE3Active, not recruiting
696 participants
Started: Dec 9, 2022 · Completed: Aug 2, 2027
1 condition1 sponsor207 locations
NCT05301192
Angiotensin-(1-7) Cardiovascular Effects in Aging
EARLY_PHASE1Recruiting
26 participants
Started: Dec 9, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors1 location